Lipocine
FD...查看全文
药渡2017-12-28 22:28
随着特朗普减税计划的实施,预测2018年将是一个药企并购大年,目前这场大战已提前打响。近日,Mallinckrodt宣布以12亿美元收购Sucampo,并得到一种上市药物——治疗便秘的Amitiza,以及两种已经处于研发后期的罕见病新药。
Mallinckrodt今年初退出美国药物研究和制造商(协会)后,实行了一系列...查看全文
hll88482016-11-26 03:03
$Sucampo Pharmaceuticals (SCMP)$ - today is Blackfriday, most of stocks have very little trade volume, but we see this one with increasing volume compared to last 5 days ave.volume. something fishy is going on. buy buy buy!!![看多]查看全文
疯狂期权FO2015-08-31 08:45
报告作者:Michael 报告出处:PPT金融
相关股票:$标普500指数ETF-SPDR(SPY)$ $纳斯达克综合指数(NASDAQ)$ $道琼斯指数(DJI30)$ $Netflix(NFLX)$ $Sucampo Pharmaceuticals (SCMP)$
8月24日开始至8月29日结束的一周周评,及下周的展望.
网页链接查看全文
深思远见2015-07-13 06:04
$Sucampo Pharmaceuticals (SCMP)$近期评级信息如下:
20150708 Maxim Group 重申相同投资评价, 评级:买入, 目标价:$20.00
更多分析和资讯,请关注微-信-公-众-号 stock_tong查看全文
Keats2015-03-27 10:06
$Sucampo Pharmaceuticals (SCMP)$ 上季度销售+54%,盈利+250%,本季度预期+500%,本年度预期+48%,连续两个季度盈利加速,基金连续两个季度增持查看全文
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-12-12,10% Owner,S&R Technology Holdings, LLC ,卖出,38462普通股, $5.28
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-12-12,CEO, Chief Scientific Officer,Ueno Ryuji ,卖出,38462普通股, $5.28
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-12-12,10% Owner,Kuno Sachiko ,卖出,38462普通股, $5.28
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-12-06,10% Owner,Kuno Sachiko ,期权,8320普通股, $4.41
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-29,CEO, Chief Scientific Officer,Ueno Ryuji ,卖出,24029普通股, $5.03
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-28,CEO, Chief Scientific Officer,Ueno Ryuji ,卖出,28028普通股, $5.02
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-29,10% Owner,Kuno Sachiko ,卖出,24029普通股, $5.03
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-28,10% Owner,Kuno Sachiko ,卖出,28028普通股, $5.02
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-29,10% Owner,S&R Technology Holdings, LLC ,卖出,24029普通股, $5.03
内部交易: $Sucampo Pharmaceuticals(SCMP)$ 2012-11-28,10% Owner,S&R Technology Holdings, LLC ,卖出,28028普通股, $5.02